30-09-2024 06:07 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Aurobindo Pharma Ltd.
Change Company   
BSE Code 524804
ISIN Demat INE406A01037
Book Value 345.24
NSE Code AUROPHARMA
Dividend Yield % 0.30
Market Cap 876865.25
P/E 45.88
EPS 32.91
Face Value 1  
18-Sep-2024 Aurobindo Pharma inks pact to acquire balance 49%...
18-Sep-2024 Aurobindo Pharma’s arm gets EIR for Andhra Prades...
18-Sep-2024 Aurobindo Pharma informs about disclosure
11-Sep-2024 Aurobindo Pharma informs about press release
28-Aug-2024 Aurobindo Pharma informs about analyst meet
27-Aug-2024 Aurobindo Pharma’s unit recalling products in US ...
26-Aug-2024 Announcement under Regulation 30 (LODR)-Closure ...
26-Aug-2024 USFDA pulls up Aurobindo Pharma's arm for manufac...
21-Aug-2024 Aurobindo Pharma informs about press release
19-Aug-2024 Aurobindo Pharma to commence production in China ...
19-Aug-2024 Aurobindo Pharma rises on eyeing production comme...
16-Aug-2024 Aurobindo Pharma’s arm gets warning letter from U...
16-Aug-2024 Aurobindo Pharma informs about disclosure
13-Aug-2024 Aurobindo Pharma informs about investor meeting
12-Aug-2024 Aurobindo Pharma reports strong Q1 numbers; conso...
Page 1 of 6
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’